Skip to content

Post-Operative Pain Control Following Shoulder Surgery

Post-Operative Pain Control Following Shoulder Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04622839
Enrollment
74
Registered
2020-11-10
Start date
2020-12-01
Completion date
2022-07-31
Last updated
2023-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder Pain

Brief summary

This study will evaluate overall opioid and non-narcotic analgesic use following surgical treatment for shoulder pathology, and recommend evidence based guidelines for standardized postoperative pain management.

Detailed description

There is currently very limited information in the literature regarding postoperative pain medication consumption following orthopedic shoulder surgery. To fill this knowledge gap, this study will evaluate overall opioid consumption in morphine milligram equivalents following surgical treatment for shoulder pathology.

Interventions

OTHERTylenol and NSAIDS (Ibuprofen, diclofenac)

This study will assess an aspect of perioperative care relating to pain control. Subjects will not be aware of which aspect is randomized, but will be given a list of possible aspects which will include the intervention (listed below): * Agents used in nerve block (lidocaine vs ropivacaine) * Location of injection for analgesic * Use of over-the-counter pain management (including but not limited to acetaminophen, ibuprofen, naproxen, etc.) * Type of initial opioid prescribed (including but not limited to oxycodone, tramadol, hydrocodone, etc.) * Number of pills in the initial opioid prescription * Instructions for sling wear (duration of use or type of sling) * Ice usage (duration of use and frequency of use) Blinding the participant to the randomized aspect of this study will help prevent bias in patient responses for outcome scores and medication usage.

Sponsors

American Shoulder and Elbow Surgeons
CollaboratorOTHER
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

participants will be masked to the aspect of post-operative pain management being manipulated in this study; investigator and outcomes assessor will be masked to randomization (group assignment) of participants

Intervention model description

Participants undergoing shoulder surgery will be randomized into one of the three study arms.

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Opioid-naive adults age 18-90 years old planning to undergo surgical treatment for shoulder pathology with the PI at Johns Hopkins Shoulder Service (Columbia, Odenton clinic sites; Howard County General Hospital/Johns Hopkins Hospital operative sites) will be included.

Exclusion criteria

* Patients with prior history of opioid misuse, addiction, or chronic pain * Patients taking chronic pain medication or have taken opioid medication in the past 3 months will be excluded due to risk of developing drug tolerances that could affect the amount of pain medication consumed after surgery An exception will be made for those who have used narcotic medication for fracture-related events, and expect to undergo surgical treatment for fracture repair (ORIF or arthroplasty) * Patients with BMI \< 18.5 or \> 39.9 * Patients with a history of adverse reaction and/or allergy to oxycodone * Patients lacking the ability to consent will also be excluded. * Patients whose primary residence is outside the United States will be excluded. * Patients who are unable to complete questionnaires due to medical condition, psychiatric illness, or significant language barrier will also be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Morphine milligram equivalents (MMEs) consumed2 weeks postopTotal possible narcotic pain medication use in MME's
Opioid Prescription Refills2 weeks postopnumber and quantity of opioid prescription refills
Office Contacts2 weeks postopNumber of times patient contacted the office via telephone, MyChart, or email

Secondary

MeasureTime frameDescription
American Shoulder and Elbow Surgeons (ASES) score2-4 months postopstandardized questionnaire for the assessment of shoulder function; single score which ranges from 0-100 with higher score reflecting higher function

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026